Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia

8Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In order to detect T cells against several chronic myeloid leukaemia (CML)-associated antigens we used: (i) a novel T-cell assay [cytometric bead array (CBA)]; (ii) γ-interferon enzyme-linked immunoSPOT (γ-IFN-ELISpot); and (iii) tetramer staining in peripheral blood from CML patients. Peptide-specific cytokine release was detected by CBA in some patients, whereas standard γ-IFN-ELISpot and tetramer staining were negative in the vast majority of cases. In CBA, peptide-specific cytokine release was predominantly tumour necrosis factor-α, raising questions about the responding cells and their functional status. CBA appears to be a new useful tool for the detection of leukaemia-reactive T cells. © 2005 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Westermann, J., Van Lessen, A., Schlimper, C., Baskaynak, G., Coutre, P. L., Dörken, B., & Pezzutto, A. (2006). Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia. British Journal of Haematology, 132(1), 32–35. https://doi.org/10.1111/j.1365-2141.2005.05844.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free